Proceedings: Is thymoxamine a specific alpha-adrenoceptor blocking agent?
D000317:Adrenergic alpha-Antagonists; D000818:Animals; D004558:Electric Stimulation; D006168:Guinea Pigs; D007001:Hypogastric Plexus / Q000187:drug effects*; D066298:In Vitro Techniques; D008297:Male; D013948:Moxisylyte / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects*; D014649:Vas Deferens / Q000187:drug effects* / Q000502:physiology
D000317:Adrenergic alpha-Antagonists; D011941:Receptors, Adrenergic; D010656:Phenylephrine; D013948:Moxisylyte; D010646:Phentolamine